logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Evandro de Azambuja

Novartis
H指数:85
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study

内分泌治疗联合CDK4/6抑制剂后进展的ER阳性/HER2阴性晚期乳腺癌中依维莫司的有效性：EVERGREEN研究

Breast Cancer Research and Treatment
IF3
2026-07-100
PRE
Diogo Martins-Branco; Soraia Lobo-Martins; Philippe Aftimos; Bernardo Pereira; Leonor Vasconcelos de Matos; Leonor Fernandes; Elsa Campôa; Guilherme Nader-Marta; Michel Moreau; Donatienne Taylor; Francois P. Duhoux; Pedro Simões; Ana Rita Garcia; Vanessa Patel; Caterina Confente; Diogo Alpuim Costa; José Pereira; Catarina Santos; Marianne Paesmans; Frederico Sarmento; Teresa Gantes Padrão; Diana Simão; Daniel Bandarra; Berta Sousa; Margarida Brito; Andrea Gombos; Lieveke Ameye; Evandro de Azambuja
Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06/NCCTG N063D (Alliance)]

人表皮生长因子受体2（HER2）阳性乳腺癌患者中的术后放疗：辅助拉帕替尼和/或曲妥珠胺治疗优化（ALTTO）试验（BIG 2-06/NCCTG N063D（Alliance））的回顾性探索性队列分析

EClinicalMedicine
IF10
2026-07-010
PRE
De Santis, Maria Carmen; Campbell, Christine; Samy, Faye; De Rose, Fiorenza; Meduri, Bruno; Lambertini, Matteo; Sotiriou, Christos; Carnevale, Maria Grazia; Ferro, Antonella; Saura, Cristina; Choudhury, Anup; Giandini, Carlotta; Verderio, Paolo; Chumsri, Saranya; Appierto, Valentina; Piccart, Martine; Pruneri, Giancarlo; Colciago, Riccardo Ray; de Azambuja, Evandro; Di Cosimo, Serena
Body Mass Index in Postmenopausal Women with Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer: An Exploratory Analysis of the LORELEI trial.

雌激素受体阳性、HER2阴性早期乳腺癌绝经后女性中的体重指数：LORELEI试验的探索性分析

European Journal of Cancer
IF7.1
2026-06-120
PRE
Chiara Dauccia; Maria Alice Franzoi; Cristina Saura; Dominik Hlauschek; Lidija Sölkner; Michael Gnant; Peter C. Dubsky; Ruth Helfgott; Gabriele Zoppoli; Mafalda Oliveira; Laetitia Collet; Jill Fredrickson; Timothy R. Wilson; Luca Arecco; Elisa Agostinetto; Evandro de Azambuja
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
New England Journal of Medicine
IF78.5
2026-01-2216
PRE
Tolaney, Sara M.; de Azambuja, Evandro; Kalinsky, Kevin; Loi, Sherene; Kim, Sung-Bae; Yam, Clinton; Rapoport, Bernardo; Im, Seock-Ah; Pistilli, Barbara; Mchayleh, Wassim; Cescon, David W.; Watanabe, Junichiro; Banuelas, Manuel Alejandro Lara; Freitas-Junior, Ruffo; Salvador Bofill, Javier; Afshari, Maryam; Gary, Dianna; Wang, Lu; Lai, Catherine; Schmid, Peter
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors

ESMO-ESTRO关于将放射治疗与CDK4/6、HER2、PARP或mTOR抑制剂联合应用的安全性共识声明

Radiotherapy and Oncology
IF5.3
2025-12-110
OAAI
Evert S.M. van Aken; Ajeet Kumar Gandhi; Sean M. O’Cathail; Gerben Borst; Jorge Barriuso; Emmanouil Fokas; Luis Castelo-Branco; Anne Hansen Ree; Evandro de Azambuja; Stephanie Kroeze; Ilaria Colombo; Antonin Levy; Carmen Criscitiello; Maximilian Niyazi; Nadia Harbeck; Ewa Szutowicz; Gabor Liposits; Marcel Verheij; Isabelle Ray-Coquard; Paolo Tarantino
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer

RSC4All 作为一种机器学习列线图，用于预测 HR+/HER2- 淋巴结阴性早期乳腺癌的 RSClin™ 结果

ESMO Open
IF8.3
2025-10-070
OAAI
F. Jacobs; S. D’Amico; E. Ferraro; E. Agostinetto; C. Tondini; M. Gaudio; C. Benvenuti; R. Gerosa; G. Saltalamacchia; E. Zazzetti; R. Di Rienzo; R. Buonaiuto; F. Martorana; A. Chirco; R. De Sanctis; M.G. Della Porta; A. Santoro; P. Vigneri; M.G. Arpino; M. Giuliano; M. Fornier; E. de Azambuja; A. Zambelli
Characteristics, Treatment Patterns and Clinical Outcomes of Women with Maghreb Origin and Diagnosis of Breast Cancer: A Single-Center, Retrospective Cohort Study

特征、治疗模式及临床结局：具有马格里伯血统并被诊断为乳腺癌的女性——一项单中心、回顾性队列研究

Clinical Breast Cancer
IF2.5
2025-06-270
PRE
Chiara Dauccia; Diogo Martins-Branco; Michel Moreau; Lieveke Ameye; Elisa Agostinetto; Luca Arecco; Soraia Lobo-Martins; Anja Skoporc; Isabel Vilas-Boas; Masa Auprih; Ahmad Awada; Véronique Debien; Evandro de Azambuja
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study

真实世界中接受辅助紫杉醇联合曲妥珠单抗（APT）方案治疗的I期HER2阳性早期乳腺癌患者的5年结果：一项国际回顾性研究

Clinical Breast Cancer
IF2.5
2025-05-150
PRE
Soraia Lobo-Martins; Veronique Debien; Elisa Agostinetto; Marianna Sirico; Giselle de Souza Carvalho; Flavia Jacobs; Chiara Molinelli; Renata Colombo Bonadio; Pedro Bergmann; Cristiano de Pádua Souza; Laura Testa; Marina Nishimuni; André João Rossi; Gabriel Kamei Guimarães; Michel Moreau; Ugo De Giorgi; José Bines; Armando Santoro; Donatienne Taylor; Francois P. Duhoux; Giacomo Barchiesi; Matteo Lambertini; Martine Piccart; Evandro de Azambuja

研究方向

暂未获取到该数据
M
Martine Piccart
H 指数:149论文数:1,553被引数:11.5万
M
Matteo Lambertini
H 指数:66论文数:755被引数:1.7万
E
Elisa Agostinetto
H 指数:25论文数:203被引数:2,708
S
Serena Di Cosimo
H 指数:48论文数:461被引数:1.0万
N
Noam Pondé
H 指数:24论文数:131被引数:2,199
L
Lieveke Ameye
H 指数:52论文数:396被引数:1.0万
M
Marco Bruzzone
H 指数:33论文数:253被引数:4,083
M
Marianne Paesmans
H 指数:66论文数:838被引数:1.8万
R
Richard D. Gelber
H 指数:133论文数:594被引数:9.0万
M
Marcello Ceppi
H 指数:49论文数:246被引数:1.0万